search icon
  • Print
  • ShareThis
  • Text Size
  • Statement on the Implications of HPTN 052 for the U.S. Response to Domestic and Global AIDS

    The following policy statement responds to the results of the HPTN 052 study, sponsored by the National Institute of
    Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH),which found that HIV‐infected men and
    women with relatively healthy immune systems who received immediate oral antiretroviral therapy (ART) were more
    than 96 percent less likely to sexually transmit the infection to their uninfected partners and were more than 40 percent
    less likely to experience a clinical event than those whose treatment was delayed. The findings from the HPTN 052 study
    provide further urgency to the quest to expand access to HIV treatment. These policy recommendations will be updated
    to reflect significant scientific discoveries related to the prevention, care and treatment of HIV disease.

    Read Full Policy Statement 

| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site